Friday 6 November 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.

Revenue: −0.43%
EPS: −7.98%
Free cash flow: +20.0%
Total debt: +1.55%

Quarter to September 2026, against a year earlier

29.96 0.83 −2.70%

Follow PFE

Alert me

Market cap: $170.3B
P/E: 42.2×
Fwd P/E: 18.9×
Dividend yield: 7.18%
F-score: 6/9
Altman Z: 2.03
Beneish M: −2.52
Dividend safety: 28/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	40.14	31.68	21.44	18.31	+8 more quarters Free account
P/S ratio Full definition →	2.56	2.15	2.52	2.26
P/FCF ratio Full definition →	14.80	13.47	18.40	17.10
P/Operating CF Full definition →	30.24	164.35	61.11	26.46
P/B ratio Full definition →	1.82	1.61	1.77	1.63
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	3.32	2.96	3.34	3.08
EV/EBITDA Full definition →	10.48	9.25	10.00	9.25
EV/Operating CF Full definition →	14.88	14.08	17.62	16.46
EV/FCF Full definition →	19.20	18.53	24.32	23.28
Quick Ratio Full definition →	0.90	0.74	0.75	0.69
Current Ratio Full definition →	1.42	1.27	1.25	1.16
Net Debt/EBITDA Full definition →	9.22	10.99	9.10	11.23
Debt/Assets Full definition →	30.64%	31.42%	31.04%	31.13%
Debt/Equity Full definition →	0.70	0.74	0.71	0.75
Asset Turnover Full definition →	0.31	0.31	0.30	0.30
Operating CF/Net income Full definition →	1.66	(3.37)	0.97	(3.25)
Capex/Depreciation Full definition →	(0.36)	(0.33)	(0.27)	(0.50)
Research and Development Expense of Revenue Full definition →	18.19%	18.68%	17.23%	18.26%
Selling, General and Administrative Expense of Revenue Full definition →	19.77%	22.69%	20.49%	23.71%
Intangible Assets out of Total Assets Full definition →	0.57	0.59	0.60	0.60
Share Based Compensation of Revenue Full definition →	2.18%	1.66%	1.88%	1.28%
Graham Net Nets Full definition →	(0.43)	(0.54)	(0.47)	(0.55)
Graham Number Full definition →	15.83	16.02	21.64	21.62
Earnings Yield Full definition →	2.49%	3.16%	4.67%	5.46%
Free Cash Flow Yield Full definition →	6.76%	7.42%	5.43%	5.85%
Revenue per Share Full definition →	2.91	2.64	2.54	3.09
Operating CF per Share Full definition →	0.94	0.15	0.46	0.94
Capex per Share Full definition →	(0.10)	(0.09)	(0.08)	(0.15)
Free Cash Flow per Share Full definition →	0.84	0.05	0.38	0.79
Cash per Share Full definition →	2.50	2.05	2.30	2.39
Shareholders Equity per Share Full definition →	15.67	15.00	15.89	15.27
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	15.67	15.00	15.89	15.27
Free Cash Flow Full definition →	4,802.00	302.00	2,179.00	4,503.00
Working Capital Full definition →	13,283.00	8,712.00	8,474.00	5,914.00
Capital Expenditures Full definition →	(573.00)	(533.00)	(436.00)	(845.00)
Net Current Asset Value Full definition →	(70,234.00)	(74,281.00)	(74,392.00)	(78,487.00)
EV/EBIT Full definition →	15.47	13.66	14.53	13.53
Capex to Sales Full definition →	0.03	0.04	0.03	0.05
Price to Operating Income Full definition →	11.92	9.93	10.99	9.93
Other line items
Average Receivables Full definition →	14,226.00	12,284.00	12,215.00	11,668.50
Average Payables Full definition →	4,547.00	4,873.50	4,873.00	5,436.50
Average Inventory Full definition →	10,745.00	10,807.00	10,759.50	10,752.50
Average Assets Full definition →	206,637.50	203,613.00	207,823.00	210,778.00
Average Common Equity Full definition →	91,198.50	87,252.00	90,520.00	87,636.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly